StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.96+0.00 (0.00%)

Close on Nov 13, 2026Market cap $59.76MP/E –Yield –

XBiotech r&d expenses

Research and development expenses are spending on new products and technology.

XBiotech's R&D Expenses for the twelve months ending Sep 30, 2026 was $40.52M, up 35.7% year over year. For fiscal 2025 it was $47.39M, up 25.5% from the year before. Over ten years it grew 4.2% a year on average. The highest annual figure on record is $47.39M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$47.39M+25.5%
FY2024Dec 31, 2024$37.76M+14.9%
FY2023Dec 31, 2023$32.85M+4.1%
FY2022Dec 31, 2022$31.54M+11.6%
FY2021Dec 31, 2021$28.27M+196.7%
FY2020Dec 31, 2020$9.53M-60.5%
FY2019Dec 31, 2019$24.09M+53.2%
FY2018Dec 31, 2018$15.73M-40.5%
FY2017Dec 31, 2017$26.42M-37.8%
FY2016Dec 31, 2016$42.49M+35.7%
FY2015Dec 31, 2015$31.31M+118.5%
FY2014Dec 31, 2014$14.33M+80.6%
FY2013Dec 31, 2013$7.94M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$4.66M-8.3%
Q2 FY2026Jun 30, 2026$5.30M-0.7%
Q1 FY2026Mar 31, 2026$5.21M-55.2%
Q4 FY2025Dec 31, 2025$25.36M+224.2%
Q3 FY2025Sep 30, 2025$5.08M-28.7%
Q2 FY2025Jun 30, 2025$5.34M-58.9%
Q1 FY2025Mar 31, 2025$11.62M+18.3%
Q4 FY2024Dec 31, 2024$7.82M+0.2%
Q3 FY2024Sep 30, 2024$7.13M-5.6%
Q2 FY2024Jun 30, 2024$12.98M+15.2%
Q1 FY2024Mar 31, 2024$9.83M+57.7%
Q4 FY2023Dec 31, 2023$7.80M+6.7%
Q3 FY2023Sep 30, 2023$7.55M+7.6%
Q2 FY2023Jun 30, 2023$11.27M+8.4%
Q1 FY2023Mar 31, 2023$6.23M-8.6%
Q4 FY2022Dec 31, 2022$7.32M-16.7%
Q3 FY2022Sep 30, 2022$7.01M+25.3%
Q2 FY2022Jun 30, 2022$10.39M+12.3%
Q1 FY2022Mar 31, 2022$6.82M+47.1%
Q4 FY2021Dec 31, 2021$8.78M+153.7%
Q3 FY2021Sep 30, 2021$5.60M+138.7%
Q2 FY2021Jun 30, 2021$9.25M+260.8%
Q1 FY2021Mar 31, 2021$4.63M+301.2%
Q4 FY2020Dec 31, 2020$3.46M-66.5%
Q3 FY2020Sep 30, 2020$2.35M-48.2%
Q2 FY2020Jun 30, 2020$2.57M-45.3%
Q1 FY2020Mar 31, 2020$1.16M-74.5%
Q4 FY2019Dec 31, 2019$10.34M+113.4%
Q3 FY2019Sep 30, 2019$4.53M+15.1%
Q2 FY2019Jun 30, 2019$4.69M+18.8%
Q1 FY2019Mar 31, 2019$4.53M+51.3%
Q4 FY2018Dec 31, 2018$4.84M-18.0%
Q3 FY2018Sep 30, 2018$3.94M-20.1%
Q2 FY2018Jun 30, 2018$3.95M-46.6%
Q1 FY2018Mar 31, 2018$2.99M-63.4%
Q4 FY2017Dec 31, 2017$5.91M-56.8%
Q3 FY2017Sep 30, 2017$4.93M–
Q2 FY2017Jun 30, 2017$7.40M–
Q1 FY2017Mar 31, 2017$8.19M–
Q4 FY2016Dec 31, 2016$13.69M–

More XBiotech figures

See a number that looks wrong?